Jennifer Pursley1, Issam El Naqa2, Nina N Sanford3, Bridget Noe1, Jennifer Y Wo1, Christine E Eyler1, Matthew Hwang1, Kristy K Brock4, Beow Y Yeap5, John A Wolfgang1, Theodore S Hong1, Clemens Grassberger6. 1. Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts. 2. Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. 3. Department of Radiation Oncology, University of Texas Southwestern, Dallas, Texas. 4. Department of Imaging Physics, The University of Texas, MD Anderson Cancer Center, Houston, Texas. 5. Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts. 6. Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: Grassberger.Clemens@mgh.harvard.edu.
Abstract
PURPOSE: This study aimed to develop robust normal-tissue complication probability (NTCP) models for patients with hepatocellular carcinoma treated with radiation therapy (RT) using Child-Pugh (CP) score and albumin-bilirubin (ALBI) grade increase as endpoints for hepatic toxicity. METHODS AND MATERIALS: Data from 108 patients with hepatocellular carcinoma treated with RT between 2008 and 2017 were evaluated, of which 47 patients (44%) were treated with proton RT. Of these patients, 29 received stereotactic body RT and 79 moderately hypofractionated RT to median physical tumor doses of 43 Gy in 5 fractions and 59 Gy in 15 fractions, respectively. A generalized Lyman-Kutcher-Berman (LKB) model was used to model the NTCP using 2 clinical endpoints, both evaluated at 3 months after RT: CP score increase of ≥2 and ALBI grade increase of ≥1 from the pre-RT baseline. Confidence intervals on LKB fit parameters were determined using bootstrap resampling. RESULTS: Compared with previous NTCP models, this study found a stronger correlation between normal liver volume receiving low doses of radiation (5-10 Gy) and a CP score or ALBI grade increase. A CP score increase exhibited a stronger correlation to normal liver volumes irradiated than an ALBI grade increase. LKB models for CP increase found values for the volume-effect parameter of a = 0.06 for all patients, and a = 0.02/0.09 when fit to photon/proton patients separately. Subset analyses for patients with superior initial liver functions showed consistent dose-volume effects (a = 0.1) and consistent dose-response relationships. CONCLUSIONS: This study presents an update of liver NTCP models in the era of modern RT techniques using relevant endpoints of hepatic toxicity, CP score and ALBI grade increase. The results show a stronger influence of low-dose bath on hepatic toxicity than those found in previous studies, indicating that RT techniques that minimize the low-dose bath may be beneficial for patients.
PURPOSE: This study aimed to develop robust normal-tissue complication probability (NTCP) models for patients with hepatocellular carcinoma treated with radiation therapy (RT) using Child-Pugh (CP) score and albumin-bilirubin (ALBI) grade increase as endpoints for hepatic toxicity. METHODS AND MATERIALS: Data from 108 patients with hepatocellular carcinoma treated with RT between 2008 and 2017 were evaluated, of which 47 patients (44%) were treated with proton RT. Of these patients, 29 received stereotactic body RT and 79 moderately hypofractionated RT to median physical tumor doses of 43 Gy in 5 fractions and 59 Gy in 15 fractions, respectively. A generalized Lyman-Kutcher-Berman (LKB) model was used to model the NTCP using 2 clinical endpoints, both evaluated at 3 months after RT: CP score increase of ≥2 and ALBI grade increase of ≥1 from the pre-RT baseline. Confidence intervals on LKB fit parameters were determined using bootstrap resampling. RESULTS: Compared with previous NTCP models, this study found a stronger correlation between normal liver volume receiving low doses of radiation (5-10 Gy) and a CP score or ALBI grade increase. A CP score increase exhibited a stronger correlation to normal liver volumes irradiated than an ALBI grade increase. LKB models for CP increase found values for the volume-effect parameter of a = 0.06 for all patients, and a = 0.02/0.09 when fit to photon/proton patients separately. Subset analyses for patients with superior initial liver functions showed consistent dose-volume effects (a = 0.1) and consistent dose-response relationships. CONCLUSIONS: This study presents an update of liver NTCP models in the era of modern RT techniques using relevant endpoints of hepatic toxicity, CP score and ALBI grade increase. The results show a stronger influence of low-dose bath on hepatic toxicity than those found in previous studies, indicating that RT techniques that minimize the low-dose bath may be beneficial for patients.
Authors: Awalpreet S Chadha; Jillian R Gunther; Cheng-En Hsieh; Maureen Aliru; Lakshmi S Mahadevan; Bhanu P Venkatesulu; Christopher H Crane; Prajnan Das; Joseph M Herman; Eugene J Koay; Cullen Taniguchi; Emma B Holliday; Bruce D Minsky; Yelin Suh; Peter Park; Gabriel Sawakuchi; Sam Beddar; Bruno C Odisio; Sanjay Gupta; Evelyne Loyer; Harmeet Kaur; Kanwal Raghav; Milind M Javle; Ahmed O Kaseb; Sunil Krishnan Journal: Radiother Oncol Date: 2019-01-16 Impact factor: 6.280
Authors: Seok Hyun Son; Byung Ock Choi; Mi Ryeong Ryu; Young Nam Kang; Ji Sun Jang; Si Hyun Bae; Seung Kew Yoon; Ihl Bohng Choi; Ki Mun Kang; Hong Seok Jang Journal: Int J Radiat Oncol Biol Phys Date: 2010-03-06 Impact factor: 7.038
Authors: Gonzalo Sapisochin; Aisling Barry; Mark Doherty; Sandra Fischer; Nicolas Goldaracena; Roizar Rosales; Moises Russo; Rob Beecroft; Anand Ghanekar; Mamatha Bhat; James Brierley; Paul D Greig; Jennifer J Knox; Laura A Dawson; David R Grant Journal: J Hepatol Date: 2017-02-28 Impact factor: 25.083
Authors: Young Seok Seo; Mi-Sook Kim; Sung Yul Yoo; Chul Koo Cho; Chul Won Choi; Jin Ho Kim; Chul Ju Han; Su Cheol Park; Byung Hee Lee; Young Han Kim; Dong Han Lee Journal: J Surg Oncol Date: 2010-09-01 Impact factor: 3.454
Authors: Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2018-09-12 Impact factor: 508.702
Authors: Issam El Naqa; Adam Johansson; Dawn Owen; Kyle Cuneo; Yue Cao; Martha Matuszak; Latifa Bazzi; Theodore S Lawrence; Randall K Ten Haken Journal: Int J Radiat Oncol Biol Phys Date: 2018-02-01 Impact factor: 7.038
Authors: Ibrahim Chamseddine; Yejin Kim; Brian De; Issam El Naqa; Dan G Duda; John Wolfgang; Jennifer Pursley; Harald Paganetti; Jennifer Wo; Theodore Hong; Eugene J Koay; Clemens Grassberger Journal: JCO Clin Cancer Inform Date: 2022-02
Authors: Ali Ajdari; Yunhe Xie; Christian Richter; Maximilian Niyazi; Dan G Duda; Theodore S Hong; Thomas Bortfeld Journal: JCO Clin Cancer Inform Date: 2021-03
Authors: Jimm Grimm; Lawrence B Marks; Andrew Jackson; Brian D Kavanagh; Jinyu Xue; Ellen Yorke Journal: Int J Radiat Oncol Biol Phys Date: 2021-05-01 Impact factor: 8.013
Authors: Meng Qing Xu; Jin Jin Dai; Zhi Sheng Jiang; Fang Xu; Long Wang; Wen Jie Zhang; Zhi Guo Guo Journal: Cancer Manag Res Date: 2020-12-07 Impact factor: 3.989